1-20 of 49
Kebede Begna
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

TP53 Variant Allele Frequency and Therapy-Related Setting Independently Predict Survival in Myelodysplastic Syndromes with Del(5q)

Farah Fleti, Onyee Chan, Najla H Al Ali, Aref Al-Kali, Kebede Begna, James M. Foran, Talha Badar, Nandita Khera, Mithun V Shah, Devendra Hiwase, Eric Padron, David A Sallman, Animesh D. Pardanani, Daniel A. Arber, Attilio Orazi, Kaaren K. Reichard, Rong He, Rhett Ketterling, Naseema Gangat, Rami S. Komrokji, Ayalew Tefferi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3234.
https://doi.org/10.1182/blood-2023-185023
Published: 2023
Journal Articles

Comparison of World Health Organization and International Consensus Classification Guidelines for Myeloid Neoplasms Harboring TP53 -Mutations Using an Independent International Cohort

Mithun V Shah, Monika Kutyna, Syed Shah, Elizabeth Ngoc Hoa Tran, Anmol Baranwal, Dariusz Ladon, Aref Al-Kali, Anna Brown, Dong Chen, Patricia Greipp, Kebede Begna, Mark R. Litzow, William J. Hogan, Peter Bardy, Sharad Kumar, David T Yeung, Mrinal M. Patnaik, James M. Foran, Rong He, Naseema Gangat, Hamish S Scott, Cecilia Y. Arana Yi, Hassan Alkhateeb, Abhishek A Mangaonkar, Daniel Thomas, Christopher Norman Hahn, Attilio Orazi, Daniel A. Arber, Chung Hoow Kok, Ayalew Tefferi, Devendra Hiwase
Journal: Blood
Blood (2023) 142 (Supplement 1): 3243.
https://doi.org/10.1182/blood-2023-187860
Published: 2023
Journal Articles

ELN 2022 Favorable Genetic Risk Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agent: Predictors of Response and Survival

Kristen McCullough, Omer Karrar, Moazah Iftikhar, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 5925.
https://doi.org/10.1182/blood-2023-182326
Published: 2023
Journal Articles

STAG2 and PHF6 : Comparison of 2 X-Linked Gene Mutations in Myeloid Neoplasms

Bahga Katamesh, Amrutha Mittapalli, Rong He, David Viswanatha, Dragan Jevremovic, Mehrdad Hefazi, Antoine Saliba, Abhishek A Mangaonkar, Kebede Begna, William J. Hogan, Naseema Gangat, Mrinal M. Patnaik, Mithun V Shah, Ayalew Tefferi, Mark R. Litzow, Hassan Alkhateeb, Aref Al-Kali
Journal: Blood
Blood (2023) 142 (Supplement 1): 4304.
https://doi.org/10.1182/blood-2023-178244
Published: 2023
Journal Articles

Survival and Prognosis Among 301 Patients with Newly-Diagnosed Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy

Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla Johnson, Maymona Abdelmagid, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Mrinal M. Patnaik, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 591.
https://doi.org/10.1182/blood-2023-178837
Published: 2023
Journal Articles

A Phase 1 Study of the Oral CDK9 Inhibitor Voruciclib in Relapsed/Refractory (R/R) B-Cell Lymphoma (NHL) or Acute Myeloid Leukemia (AML)

Matthew S Davids, Yesid Alvarado Valero, Catherine Diefenbach, Daniel N. Egan, Shira N. Dinner, Monzr M. Al Malki, Kebede Begna, Avyakta Kallam, Sameem Abedin, Rachel Cook, Nathalie Javidi-Sharifi, Edward Dominguez, Lu Miao, Richard G Ghalie, Alexey Danilov
Journal: Blood
Blood (2023) 142 (Supplement 1): 4286.
https://doi.org/10.1182/blood-2023-179577
Published: 2023
Journal Articles

Pivekimab Sunirine (PVEK, IMGN632), a CD123-Targeting Antibody-Drug Conjugate, in Combination with Azacitidine and Venetoclax in Patients with Newly Diagnosed Acute Myeloid Leukemia

Naval Daver, Pau Montesinos, Jessica K. Altman, Eunice S. Wang, Giovanni Martinelli, Gail J. Roboz, Kebede Begna, Paresh Vyas, Monia Lunghi, Uwe Platzbecker, Patrick W. Burke, Roland B. Walter, Anjali S. Advani, Sylvain Garciaz, Lauris Gastaud, David A Sallman, Naveen Pemmaraju, Laura Torres, Yasmin Abaza, Onyee Chan, Hagop M. Kantarjian, Benjamin Oshrine, Yining Du, Kara Malcolm, Kendra Sweet
Journal: Blood
Blood (2023) 142 (Supplement 1): 2906.
https://doi.org/10.1182/blood-2023-173413
Published: 2023
Journal Articles

Venetoclax + Cladribine + Low-Dose Cytarabine in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax + Hypomethylating Agent

Nickolas Steinauer, Kristen McCullough, Aref Al-Kali, Hassan Alkhateeb, Kebede Begna, Abhishek A Mangaonkar, Antoine Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun V Shah, Animesh D. Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 2853.
https://doi.org/10.1182/blood-2023-185185
Published: 2023
Journal Articles

Type 1/like Calr Mutation in Momelotinib-Treated Patients with Myelofibrosis Is the Most Prominent Predictor of Drug Survival and Longevity without Transplant

Ayalew Tefferi, Animesh D. Pardanani, Kebede Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Naseema Gangat
Journal: Blood
Blood (2023) 142 (Supplement 1): 4555.
https://doi.org/10.1182/blood-2023-178869
Published: 2023
Journal Articles

Spectrum of clonal hematopoiesis in VEXAS syndrome

CME
Fernanda Gutierrez-Rodrigues, Yael Kusne, Jenna Fernandez, Terra Lasho, Ruba Shalhoub, Xiaoyang Ma, Hugh Alessi, Christy Finke, Matthew J. Koster, Abhishek Mangaonkar, Kenneth J. Warrington, Kebede Begna, Zhuoer Xie, Amanda K. Ombrello, David Viswanatha, Marcela Ferrada, Lorena Wilson, Ronald Go, Taxiarchis Kourelis, Kaaren Reichard, Horatiu Olteanu, Ivana Darden, Dalton Hironaka, Lemlem Alemu, Sachiko Kajigaya, Sofia Rosenzweig, Rodrigo T. Calado, Emma M. Groarke, Daniel L. Kastner, Katherine R. Calvo, Colin O. Wu, Peter C. Grayson, Neal S. Young, David B. Beck, Bhavisha A. Patel, Mrinal M. Patnaik
Journal: Blood
Blood (2023) 142 (3): 244–259.
https://doi.org/10.1182/blood.2022018774
Published: 2023
Includes: Supplemental data
Journal Articles

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

Devendra Hiwase, Christopher Hahn, Elizabeth Ngoc Hoa Tran, Rakchha Chhetri, Anmol Baranwal, Aref Al-Kali, Kirsty Sharplin, Dariusz Ladon, Rachel Hollins, Patricia Greipp, Monika Kutyna, Hassan Alkhateeb, Talha Badar, Paul Wang, David M. Ross, Deepak Singhal, Naranie Shanmuganathan, Peter Bardy, Ashanka Beligaswatte, David Yeung, Mark R. Litzow, Abhishek Mangaonkar, Pratyush Giri, Cindy Lee, Angie Yong, Noemi Horvath, Nimit Singhal, Raghu Gowda, William Hogan, Naseema Gangat, Mrinal Patnaik, Kebede Begna, Ing S. Tiong, Andrew Wei, Sharad Kumar, Anna Brown, Hamish Scott, Daniel Thomas, Chung H. Kok, Ayalew Tefferi, Mithun Vinod Shah
Journal: Blood
Blood (2023) 141 (9): 1087–1091.
https://doi.org/10.1182/blood.2022018236
Published: 2023
Includes: Supplemental data
Journal Articles

Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy

Rimal Ilyas, Isla McKerrow Johnson, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Mrinal M.M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2022) 140 (Supplement 1): 1286–1287.
https://doi.org/10.1182/blood-2022-165491
Published: 2022
Journal Articles

Therapy-Related Myelodysplastic Syndromes with Isolated Del(5q): Comparative Analysis of Phenotype and Long-Term Survival

Farah Fleti, Amritpal Singh, Aref Al-Kali, James M. Foran, Michelle A Elliott, Kebede Begna, Talha Badar, Nandita Khera, Mithun V. Shah, Hassan B. Alkhateeb, Maymona Abdelmagid, Kaaren K. Reichard, Rhett P. Ketterling, Animesh Pardanani, Naseema Gangat, Ayalew Tefferi
Journal: Blood
Blood (2022) 140 (Supplement 1): 6940–6941.
https://doi.org/10.1182/blood-2022-163518
Published: 2022
Journal Articles

Clinical and Molecular Characteristics of ETV6 Mutated Myeloid Malignancies

Mark Gurney, Ismahene Chekkaf, Rong He, David S. Viswanatha, Patricia Greipp, Abhishek A. Mangaonkar, Kebede Begna, Naseema Gangat, Mrinal M. Patnaik, Mark R. Litzow, James M. Foran, Talha Badar, Mithun V. Shah, Hassan B. Alkhateeb, Aref Al-Kali
Journal: Blood
Blood (2022) 140 (Supplement 1): 6912–6914.
https://doi.org/10.1182/blood-2022-170641
Published: 2022
Journal Articles

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial

Anand P. Jillella, Sandra J. Lee, Jessica K. Altman, Selina M. Luger, Martin S. Tallman, James M. Foran, Lisa Y. Law, Locke J. Bryan, Abdallah Abou Zahr, Kebede Begna, Alexander Perl, Joseph Vadakara, Federico Sanchez, Raymond C. Bergan, Michael J. Fisch, Ruth C. Carlos, Lynne I. Wagner, Mark R. Litzow, Vamsi K. Kota
Journal: Blood
Blood (2022) 140 (Supplement 1): 1011–1013.
https://doi.org/10.1182/blood-2022-163436
Published: 2022
Journal Articles

Characteristics and Outcomes of Patients with BCOR Mutated Myeloid Neoplasms

Anmol Baranwal, Mithun V. Shah, Amit Barua, Aysun Senturk Yikilmaz, Rong He, David S. Viswanatha, Talha Badar, Bahga Katamesh, Abhishek A. Mangaonkar, Naseema Gangat, Mrinal M. Patnaik, Mark R. Litzow, William J. Hogan, Kebede Begna, Ayalew Tefferi, Aref Al-Kali, Hassan B. Alkhateeb
Journal: Blood
Blood (2022) 140 (Supplement 1): 3235–3236.
https://doi.org/10.1182/blood-2022-169319
Published: 2022
Journal Articles

Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy

Isla McKerrow Johnson, Rimal Ilyas, Kristen McCullough, Aref Al-Kali, Hassan B. Alkhateeb, Kebede Begna, Abhishek A. Mangaonkar, Mark R. Litzow, William J. Hogan, Mithun V. Shah, Mrinal M. Patnaik, Animesh Pardanani, Ayalew Tefferi, Naseema Gangat
Journal: Blood
Blood (2022) 140 (Supplement 1): 3233–3234.
https://doi.org/10.1182/blood-2022-167967
Published: 2022
Journal Articles

Patterns of Lymphoproliferative Disorders in Ethiopia, Based on Single-Center Experience

Tirumebet Mezgebu Minayehu, Kebede Begna, Mesfin Asefa Tola, Biniyam Beyene Tabor, Yemesrach Fereja Mekonen, Helen Gebremariyam Hilawi
Journal: Blood
Blood (2022) 140 (Supplement 1): 12137–12138.
https://doi.org/10.1182/blood-2022-168012
Published: 2022
Journal Articles

Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3 -Mutated Acute Myeloid Leukemia (AML)

Ahmad Ghorab, Mark R. Litzow, Naseema Gangat, Aref Al-Kali, Mithun V. Shah, Hemant S. Murthy, Ayalew Tefferi, Hassan B. Alkhateeb, Kebede Begna, Mrinal M. Patnaik, James M. Foran, Talha Badar
Journal: Blood
Blood (2022) 140 (Supplement 1): 9019–9020.
https://doi.org/10.1182/blood-2022-168303
Published: 2022
Journal Articles

Monocytopenia As an Adverse Prognosticator in Vexas Syndrome

Yael Kusne, Matthew Koster, Kenneth Warrington, Ronald Go, Terra Lasho, Christy Finke, Jenna A. Fernandez, Kebede Begna, Allison M. Bock, Kaaren K. Reichard, Horatiu Olteanu, Jennifer Herrick, Mrinal M.M. Patnaik
Journal: Blood
Blood (2022) 140 (Supplement 1): 11406–11407.
https://doi.org/10.1182/blood-2022-165706
Published: 2022